Literature DB >> 10092545

The immunotolerance role of HLA-G.

N Rouas-Freiss1, I Khalil-Daher, B Riteau, C Menier, P Paul, J Dausset, E D Carosella.   

Abstract

HLA-G is a non-classical MHC class I molecule involved in immune tolerance. We present our results concerning the effects of HLA-G on the cellular immune response, where it impairs both NK and T cell functions. We describe the NK inhibitory properties of HLA-G ex vivo, demonstrating its role in materno-fetal tolerance, which is supported by our in vitro studies using membrane-bound HLA-G1- and HLA-G2-transfected cells and a full-length soluble HLA-G molecule. We also report how HLA-G interacts at the T cell level, here exemplified by its inhibitory effect on both T cell allogeneic proliferative and Ag-specific CTL responses. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092545     DOI: 10.1006/scbi.1998.0103

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  14 in total

1.  The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis.

Authors:  K Matsunami; S Miyagawa; R Nakai; A Murase; R Shirakura
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 2.  Does nitric oxide play a role in maternal tolerance towards the foetus?

Authors:  A González; A S López; E Alegre; J L Alcázar; N López-Moratalla
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

3.  Mechanisms of malignant glioma immune resistance and sources of immunosuppression.

Authors:  German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2006

4.  Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production.

Authors:  M Urosevic; M O Kurrer; J Kamarashev; B Mueller; W Weder; G Burg; R A Stahel; R Dummer; A Trojan
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 5.  Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.

Authors:  Fatma Berri; Vuong Ba Lê; Martine Jandrot-Perrus; Bruno Lina; Béatrice Riteau
Journal:  Cell Mol Life Sci       Date:  2013-10-04       Impact factor: 9.261

6.  Soluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.

Authors:  Fabio Morandi; Vito Pistoia
Journal:  Int Immunol       Date:  2012-12-05       Impact factor: 4.823

Review 7.  Soluble HLA-G: Are they clinically relevant?

Authors:  Vito Pistoia; Fabio Morandi; Xinhui Wang; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2007-07-31       Impact factor: 15.707

8.  Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection.

Authors:  Qunying Han; Na Li; Qianqian Zhu; Zhu Li; Guoyu Zhang; Jinghong Chen; Yi Lv; Yawen Wang; Zhengwen Liu; Chunqiu Hao
Journal:  Clin Exp Med       Date:  2012-09-25       Impact factor: 3.984

9.  Synthetic HLA-G proteins for therapeutic use in transplantation.

Authors:  Joel LeMaoult; Marina Daouya; Juan Wu; Maria Loustau; Anatolij Horuzsko; Edgardo D Carosella
Journal:  FASEB J       Date:  2013-06-10       Impact factor: 5.191

10.  Role of HLA-G and NCR in protection of umbilical cord blood haematopoietic stem cells from NK cell mediated cytotoxicity.

Authors:  Ming Wang; Yuhua Qiu; Xuelei Wang; Fang Zhao; Min Jin; Ming Xu; Ruiming Rong; Hailiang Ge; Yanyun Zhang; Xiangdong Wang; Tongyu Zhu
Journal:  J Cell Mol Med       Date:  2011-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.